Scorpion therapeutics sfo
Web8 Jan 2024 · The total includes $162 million from a Series B financing announced this week by the startup, Boston-based Scorpion Therapeutics co-founded by entrepreneurs with a strong track record in drug ... Web9 Jul 2024 · Founded by serial entrepreneur and former IFM Therapeutics CEO Gary Glick, Scorpion has already raised about $270 million and nearly doubled its team to about 50 people. Under Hoos' leadership,...
Scorpion therapeutics sfo
Did you know?
Web4 Apr 2024 · Scorpion receives $65 million from an upfront payment and the achievement of near-term milestones and is eligible to receive up to $553 million in potential milestones, plus royalties on net product sales; Scorpion will retain rights to STX-721 and STX-241 in the United States, Canada, and Japan; Pierre Fabre granted rights in all other global territories WebSan Francisco, CA Scorpion Therapeutics is a precision oncology company founded in February 2024 by a preeminent group of scientists from Harvard University/Massachusetts General Hospital – Keith Flaherty, MD, Gaddy Getz, Ph.D. and Liron Bar-Peled, Ph.D. The company has raised $270M in Series A and Series B financings led by blue-chip ...
Web26 Oct 2024 · Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0 -- Company building comprehensive drug hunting engine to broaden the … Web7 Jan 2024 · BOSTON-- ( BUSINESS WIRE )--Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the closing of an oversubscribed Series B …
Web4 Apr 2024 · BOSTON, MA, USA I April 03, 2024 I Scorpion Therapeutics, Inc. (“Scorpion”), a clinical-stage biotechnology company redefining the frontier of precision medicine through its Precision Oncology 2.0 strategy, today announced that it has named STX-241 as its next development candidate. STX-241 is the third development candidate nominated by … Web12 Sep 2024 · BOSTON-- ( BUSINESS WIRE )-- Scorpion Therapeutics, Inc. (“Scorpion Therapeutics”), a pioneering oncology company redefining the frontier of precision medicine, today announced the appointment of Michael Streit, M.D., M.B.A as the Company’s first Chief Medical Officer (“CMO”).
WebScorpion Therapeutics Location: San Francisco Bay Area, CA Add to My Lists more ClaimEmbed Export Amanda Valentino brings two decades of experience and leadership in talent acquisition, human resources and employee experience in the …
WebSan Francisco Latest News View all news 4th April 2024 Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with EGFR Mutant Non-Small Cell Lung Cancer 3rd April 2024 Pixium Vision announces FDA Breakthrough Device Designation for the Prima … scrap metal id fallout new vegasWebLess than three months after breaking cover with an impressive $102 million series A, Scorpion has whipped up another major funding round, nabbing $162 million for its next … scrap metal in villawoodWeb3 Apr 2024 · BOSTON--(BUSINESS WIRE)-- Scorpion Therapeutics, Inc. (“Scorpion”), a clinical-stage biotechnology company redefining the frontier of precision medicine through its Precision Oncology 2.0 strategy, today announced that it has named STX-241 as its next development candidate.STX-241 is the third development candidate nominated by … scrap metal in spanish